APA (7th ed.) Citation

DM, H., AS, L., T, S., S, P., CL, M., K, B., . . . J, J. (2012). The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. American journal of obstetrics and gynecology, 206(5), 447.e17-24. https://doi.org/10.1016/j.ajog.2012.02.016

Chicago Style (17th ed.) Citation

DM, Haas, et al. "The Impact of Drug Metabolizing Enzyme Polymorphisms on Outcomes After Antenatal Corticosteroid Use." American Journal of Obstetrics and Gynecology 206, no. 5 (2012): 447.e17-24. https://doi.org/10.1016/j.ajog.2012.02.016.

MLA (9th ed.) Citation

DM, Haas, et al. "The Impact of Drug Metabolizing Enzyme Polymorphisms on Outcomes After Antenatal Corticosteroid Use." American Journal of Obstetrics and Gynecology, vol. 206, no. 5, 2012, pp. 447.e17-24, https://doi.org/10.1016/j.ajog.2012.02.016.